Growth factor-dependent signaling and cell cycle progression (Q34164593)

31 July 2017

1 reference

title

Growth factor-dependent signaling and cell cycle progression. (English)

1 reference

31 July 2017

Jones SM

1

1 reference

31 July 2017

Kazlauskas A

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

490

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

110-116

1 reference

How proteolysis drives the cell cycle

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

A Restriction Point for Control of Normal Animal Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

G1 events and regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

The restriction point and control of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Multiple ras effector pathways contribute to G(1) cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Direct control of the Forkhead transcription factor AFX by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Negative regulation of the forkhead transcription factor FKHR by Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Receptor tyrosine kinases and their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Phosphatidylinositol-3-OH kinase as a direct target of Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

21 January 2018

Phosphoinositide kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Signalling through the lipid products of phosphoinositide-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Molecules in focus: The c-Cbl oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Control of the Balb/c-3T3 cell cycle by nutrients and serum factors: Analysis using platelet-derived growth factor and platelet-poor plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Dual control of cell growth by somatomedins and platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Prolonged vs transient roles for early cell cycle signaling components

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Cell cycle-dependent activation of Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Regulation of chemotaxis by the platelet-derived growth factor receptor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Induction of DNA synthesis in BALB/c 3T3 cells by serum components: Reevaluation of the commitment process

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

PDGF initiates two distinct phases of protein kinase C activity that make unequal contributions to the G0 to S transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2902113-5

10.1016/S0014-5793(01)02113-5

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference